Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Biological Technologies Investment and R&D

Active

Federal

Response Deadline10/09/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Biological Technologies Investment and R&D subcontract, issued by the Defense Advanced Research Projects Agency under the Department of Defense, focuses on performing biotechnology research for prime contractors on DARPA Venture Horizons projects. The scope of work includes the development of biosensors, operational resilience systems, functional restoration technologies, and tactical warfighter care solutions. To be successful, the provider must possess specialized expertise in logistical security and medical device engineering to deliver technical research and investment-ready biotech frameworks. This opportunity was posted on September 14, 2026, with a response deadline of October 9, 2026. It is categorized under NAICS code 541714, reflecting its focus on research and development in the biotechnology sector.

General Info

DARPA subcontract for biotechnology R&D focusing on biosensors and tactical warfighter care solutions.

Agency

Department Of Defense → Defense Advanced Research Projects AgcyView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

VA

Set-Aside

NONE

Documents

This scope was carved out of DARPA_09142026.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DARPA "Venture Horizons" Request for Information

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedSep 14

subcontract

Response DeadlineOct 9

Submission deadline

Response Deadline

10/09/2026, 09:00:00 PM UTCin 24 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → Defense Advanced Research Projects Agcy

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Performs biotechnology research for prime contractors on DARPA Venture Horizons projects. Develops biosensors, tactical warfighter care solutions, functional restoration technologies, and operational resilience systems. Requires expertise in medical device engineering and logistical security. Delivers technical research and investment-ready biotech frameworks.

Similar Contracts

Same NAICS industry code

Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)

Solicitation # W911SR-26-9-CADENCC

The Department of the Army, through the Army Contracting Command Edgewood Contracting Division and the Joint Project Lead Enabling Technologies, is seeking preproposals for the Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability project. This initiative aims to accelerate clinical trial startups for CBRN defense readiness by implementing Master Protocols, utilizing innovative technologies for decentralized trial operations, and establishing a pre-positioned clinical trial site network. The project will primarily focus on Phase I and Phase II clinical trials for early treatment products, post-exposure prophylaxis, and pre-exposure prophylaxis, including those under the Animal Rule. This opportunity is issued under 10 USC 4022 Other Transaction Authority for a prototype project, with the potential for non-competitive follow-on production contracts for successful performers. Preproposals are due by 1500 hours on September 17, 2026, and must be limited to 10 pages. Evaluation will be based on technical merit, military relevance, technology readiness level 4 or above, regulatory compliance with FDA guidelines, and best overall value. Prospective awardees must be registered in the System for Award Management database.

POSTED

DEADLINE

Notice of Intent to Award to a Single Source

Solicitation # PCA-NIDCD-09517

The National Institutes of Health Office of the Director Office of Acquisitions intends to award a single-source contract to the University of Illinois School of Chemical Sciences for the procurement of K101 and K110 pellets. These pellets are required by the National Institute on Deafness and Other Communication Disorders to ensure a superior steady-state, slow-release of study compounds over 90-day periods. The government has identified the University of Illinois as the sole source capable of providing the necessary quality and consistency required to maintain the integrity of ongoing study data, as commercial alternatives have proven unmatched. This notice serves as a pre-solicitation under the authority of 41 U.S.C. 3204(b)(2), and is not a formal request for proposal. However, interested vendors may submit capability statements and past performance documentation to Christine Biser by September 16, 2026, referencing solicitation PCA-NIDCD-09517. The government will evaluate these submissions to determine if the procurement should be conducted on a competitive basis, though the final decision remains at the discretion of the agency.

National Institutes Of Health

POSTED

DEADLINE

Whole genome sequencing for investigation of age-related chronic disease in HANDLS participants

Solicitation # 75N98026R00166

National Institutes Of Health Olao

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, is issuing a forecast for Stage 2 of the Somatic Mosaicism across Human Tissues (SMaHT) Genome Characterization Centers initiative. Building upon the multi-omic datasets established in Stage 1, this program aims to advance the understanding of biological processes and disease mechanisms driven by somatic mutations across various human tissues. The primary objective of the Stage 2 centers is to determine the functional consequences of somatic mutations within both healthy and clinically relevant tissue samples, specifically focusing on patients whose phenotypes are suspected to be driven by these mutations. This effort is designed to further characterize somatic mosaicism and its broader role in human biology and disease.

National Institutes Of Health

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, is issuing a forecast for the Somatic Mosaicism across Human Tissues (SMaHT) Program focusing on Experimental and Computational Technology Development. This initiative aims to advance the understanding of biological processes and disease mechanisms by developing, optimizing, and validating cost-effective technologies for somatic mutation detection and functional interpretation. Building upon the multi-omic datasets established in Stage 1, this second stage emphasizes the creation of rigorous benchmarks and the dissemination of tools to support the discovery of mutations across human tissues. Awardees will be expected to work collaboratively with other SMaHT Stage 2 initiatives to integrate these validated technologies into production workflows, data releases, and broader community resources. This multidisciplinary effort is designed to enhance the detection and analysis of somatic mutations across all three germ layers. Interested parties can contact the SMaHT Program via email for further information regarding this opportunity.

National Institutes Of Health

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)The National Institutes of Health is seeking support for Stage 2 of the Somatic Mosaicism across Human Tissues (SMaHT) Network through the establishment of the National Somatic Mosaicism Commons Data Analysis and Organizational Center. This initiative aims to advance the understanding of biological processes and disease mechanisms by leveraging multi-omic somatic mutation datasets from human tissues across all three germ layers. The Center will serve as a central hub for network governance, coordination, and the development of tools and platforms designed for both network members and the broader clinical and research communities. Key responsibilities of the Center include managing network data and creating essential resources such as the SMaHT data portal, a Variant Catalog, a variant browser, and various visualization tools. Additionally, the Center will provide analysis-ready data releases and lead outreach and training efforts to ensure the research community can effectively utilize these complex datasets. This forecasted opportunity is managed by the Department of Health and Human Services and specifically prohibits clinical trials.

National Institutes Of Health

POSTED

DEADLINE

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response Program. The primary objective is to maintain a permanent readiness posture and a commercially sustainable warm-base production capacity for the rapid manufacture of vaccines, antigens, and adjuvants during public health emergencies. Contractors are required to produce these countermeasures against influenza and other viruses with pandemic potential, generate and submit all necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data to the FDA, and support rapid regulatory decisions. To be eligible, offerors must hold a U.S. influenza vaccine license or have developed an influenza vaccine as evidenced by a Biologics License Application submission. The contract is structured as an IDIQ with a five-year base period and a potential five-year option period, totaling a possible 120-month ordering period. Award decisions will be based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology, with a significant emphasis on capabilities. Key requirements include strict adherence to CGMP guidelines, the implementation of comprehensive business and supply continuity plans, and the submission of surge manufacturing and supply chain readiness assessments. Deliverables include the preparation of candidate vaccine viruses and the management of complex logistics, including temperature-controlled shipping and specific packaging standards. Payment is processed quarterly via the Department of Treasury Invoice Processing Platform.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

Industry Day: DARPA Documentation & Decision Support Sprint (D2)

Solicitation # DARPA-SN-26-118

The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) has issued Special Notice DARPA-SN-26-118 to announce a virtual Industry Day on September 22, 2026, for the Documentation and Decision Support Sprint (D2). This initiative aims to advance combat medicine by developing autonomous solutions that use passive sensor data, such as audio, video, and accelerometry, to assist untrained individuals in delivering tactical combat casualty care during the first 20 minutes of treatment. The project is divided into two primary lanes: Lane 1 focuses on the autonomous population of digital DD Form 1380 TCCC Cards, and Lane 2 focuses on providing real-time clinical decision support for non-medics based on Committee on Tactical Combat Casualty Care and Joint Trauma System Clinical Practice Guidelines. This announcement is an informational notice and not a formal solicitation for proposals or abstracts. Interested U.S. entities and citizens must register for the Industry Day by September 20, 2026, at 5:00 PM ET, with attendance limited to the first 1,000 registrants. While no formal proposals are being accepted, prospective competitors may submit one-page teaming profiles to D2Sprint@darpa.mil by September 22, 2026, to facilitate partnership arrangements. The D2 effort will be conducted at the unclassified level and will utilize targeted prize incentives to catalyze technological advancements. Technical and administrative inquiries are directed to Dr. Jeremy Pamplin and the D2Sprint email address.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

DARPA Surgical Competition (DSC) Industry Day

Solicitation # DARPA-SN-26-125

The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is hosting an Industry Day for the DARPA Surgical Competition (DSC) on September 22, 2026, from 9:00 AM to 12:30 PM ET. This hybrid event, held in Arlington, Virginia, and virtually, aims to introduce a competition focused on developing a minimum viable product for scalable, autonomous robotic trauma surgery systems. The competition is designed to establish the state of the art for open robotic trauma surgery and identify technologies for autonomous surgical assistance. Performance will be evaluated through three primary lanes: Component Gates, which assess system safety and autonomy across medical knowledge, physical capability, and rapid learning; Surgical Collaboration, which tests the platform's ability to work alongside a human surgeon; and Surgical Independence, which evaluates the system's ability to plan and execute end-to-end trauma procedures without assistance. While this special notice is not a formal request for proposals, interested parties are invited to participate by registering and optionally submitting materials by September 18, 2026. These materials include a single-slide landscape PDF for a three-minute lightning talk and a teaming profile detailing technical competencies and collaboration goals. All submissions must contain only unclassified, non-proprietary information. Technical and administrative inquiries are managed by Program Manager Jeremy Pamplin via the SurgicalCompetition@darpa.mil email address.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Human Hindbrain Organoid Functional Assay Services.

Solicitation # RFQ_CDR-2026-135968

The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Hypoxia Chamber Services

Solicitation # 80JSC026Q0008

NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.

NASA Johnson Space Center

POSTED

DEADLINE

Hypobaric Chamber Pilot Studies

Solicitation # 80JSC026Q0006

NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.

NASA Johnson Space Center

POSTED

DEADLINE

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

AI and Cyber Operations Investment and R&DThis subcontract for the Defense Advanced Research Projects Agency focuses on AI and Cyber Operations Investment and R&D to support prime contractors on DARPA Venture Horizons projects. The scope of work involves developing proficient AI, cyber operations advantages, information domain confidence, and resilient, secure systems. The project requires specialized expertise in cybersecurity consulting and secure systems architecture to deliver technical research and investment-ready technology frameworks. The opportunity was posted on September 14, 2026, with a response deadline of October 9, 2026. It is categorized under NAICS code 541715 and is managed under the Department of Defense.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

BEAMERS Industry Day Announcement

Solicitation # DARPA-SN-26-122

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Solicitation # DARPA-PS-26-127

The Defense Advanced Research Projects Agency (DARPA) Multi X Office is soliciting innovative proposals under solicitation DARPA-PS-26-127, titled Perrseus, to develop microscale ultra-high-vacuum systems (uUHV). The program aims to enable compact cold-atom devices and environmentally-decoupled ultra-high Q microelectromechanical (MEMS) and photonics devices, specifically targeting manufacturable vacuum packages with pressures below 10^-10 mbar. The effort is structured as an Other Transaction for Prototype Agreement under 10 U.S.C. 4022, with an estimated period of performance of 42 months starting January 15, 2027. This includes a three-month Phase 0 for security set-up followed by technical development phases. Proposals are evaluated based on overall scientific and technical merit, potential contribution to the DARPA mission, and budget, price, and schedule. Key requirements include CMMC Level 2 self-assessment and strict adherence to Controlled Unclassified Information (CUI) handling guidelines. The program emphasizes low Size, Weight, and Power (SWaP) and high-volume manufacturability. Awardees must deliver ten functional prototypes and undergo in-person government validation of vacuum metrics. The submission process requires a technical and management volume, a detailed price volume, and an oral presentation, with a final proposal deadline of September 23, 2026.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

DARPA "Venture Horizons" Request for Information

Solicitation # DARPA_09142026

Portfolio Management and Investment Advice

POSTED

DEADLINE

Passive Sensor Suite Supply and IntegrationThis subcontract with the Defense Advanced Research Projects Agency involves the supply and integration of a passive sensor suite for prime contractors on Biological Technologies Office projects. The scope of work focuses on providing high-fidelity audio and video capture devices along with accelerometers designed for movement and action tracking that are compatible with D2 algorithms. The deliverables consist of integrated passive sensor hardware kits that must meet military-grade durability standards to ensure functionality within combat medicine environments. This effort falls under NAICS code 334111 and is managed by the Department of Defense.

Electronic Computer Manufacturing

POSTED

DEADLINE

Tactical Combat Casualty Care (TCCC) Decision Support DevelopmentThis subcontract with the Defense Advanced Research Projects Agency focuses on the development of autonomous decision support tools designed to assist untrained individuals in providing tactical combat casualty care. The project involves creating decision-logic frameworks that utilize passive sensor inputs from the initial twenty minutes of care to provide critical field medical guidance. The development process must strictly adhere to CoTCCC Guidelines and JTS CPGs to ensure medical accuracy and safety. The final deliverable is a specialized software tool intended for use by prime contractors on DARPA Biological Technologies Office projects to improve casualty care outcomes in tactical environments.

Computer Systems Design Services

POSTED

DEADLINE

AI/ML Development for Autonomous TCCC DocumentationThis subcontract with the Defense Advanced Research Projects Agency focuses on the development of AI and ML algorithms designed to autonomously populate digital DD Form 1380 TCCC cards. The project involves processing passive sensor data, specifically audio, video, and accelerometry, to accurately map inputs to required medical fields. All development must strictly adhere to CoTCCC Guidelines and JTS CPGs to ensure medical accuracy and compliance. The primary deliverable is an autonomous algorithm software module capable of automating the documentation process for prime contractors on Biological Technologies Office projects. This effort falls under NAICS code 541512 and is managed by the Department of Defense.

Computer Systems Design Services

POSTED

DEADLINE

Trauma Care Clinical Integration & ValidationThe Trauma Care Clinical Integration and Validation subcontract supports DARPA surgical competition projects by providing essential clinical research and validation services for prime contractors. The scope of work involves defining clinical requirements for trauma surgery, designing rigorous validation protocols, and offering specialized medical subject matter expertise. To achieve these goals, the project utilizes clinical simulation labs and trauma mannequins to ensure high-fidelity testing and accuracy. Managed under NAICS code 541715 for the Defense Advanced Research Projects Agency within the Department of Defense, the contract requires the delivery of formal clinical requirement documents and comprehensive validation reports. The opportunity was posted on September 11, 2026, with a response deadline of September 16, 2026.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

in about 23 hours

Teleoperation System DevelopmentThe Teleoperation System Development subcontract, issued by the Defense Advanced Research Projects Agency under the Department of Defense, focuses on the creation of user interfaces and control systems for surgical competition projects. The scope of work involves designing master-slave control architectures, ergonomic surgeon consoles, and low-latency communication links to enable precise remote human control of surgical robots. Technical execution requires the use of specialized teleoperation consoles and low-latency networking hardware to ensure seamless system performance. This project falls under NAICS code 541330 and was posted on September 11, 2026, with a response deadline of September 16, 2026.

Engineering Services

POSTED

DEADLINE

in about 23 hours

Surgical Perception & Sensing IntegrationThe Surgical Perception and Sensing Integration subcontract, issued by the Defense Advanced Research Projects Agency under the Department of Defense, focuses on providing advanced sensors and computer vision systems for prime contractors participating in DARPA surgical competition projects. The scope of work involves the implementation of 3D vision, depth sensing, haptic feedback, and real-time image processing to create a comprehensive perception system that delivers critical environmental data to control algorithms. To achieve these objectives, the project utilizes a sophisticated hardware suite including stereo cameras, LiDAR, force-torque sensors, and haptic interfaces. This technical integration is categorized under NAICS code 334517, with the contract posted on September 11, 2026, and a response deadline set for September 16, 2026.

Irradiation Apparatus Manufacturing

POSTED

DEADLINE

in about 23 hours

Autonomous Surgical AI & Control AlgorithmsThis subcontract, titled Autonomous Surgical AI & Control Algorithms, supports prime contractors on DARPA surgical competition projects under the Department of Defense. The scope of work focuses on software engineering and AI development, specifically creating algorithms for autonomous tissue manipulation, motion planning, and rapid capability learning. The technical execution involves the use of machine learning frameworks, simulation environments, and high-compute GPU clusters to deliver integrated AI models and control software for robotic platforms. This opportunity falls under NAICS code 541511 and was posted on September 11, 2026, with a response deadline of September 16, 2026.

Custom Computer Programming Services

POSTED

DEADLINE

in about 23 hours

Specialized Surgical Endeffectors & ToolingThis subcontract focuses on the supply and development of specialized surgical endeffectors for prime contractors participating in DARPA surgical competition projects. The scope of work involves the design, prototyping, and testing of critical surgical tools, including cutters, graspers, and suturing instruments intended for integration with robotic platforms. To ensure medical efficacy and safety, the project utilizes high-grade materials such as titanium, surgical-grade steel, and micro-machined biocompatible components. Managed under the Department of Defense for the Defense Advanced Research Projects Agency, the contract requires the delivery of a complete suite of functional surgical endeffectors. The opportunity is categorized under NAICS code 339113 and was posted on September 11, 2026, with a response deadline of September 16, 2026.

Surgical Appliance and Supplies Manufacturing

POSTED

DEADLINE

in about 23 hours

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 650+ contractors already using CLEATUS